Cencora (COR) stock
Last close $341.25 on 2026-11-19 (-2.03%) · Sector: Healthcare
Cencora, formerly AmerisourceBergen, is a large drug distributor that moves prescription medicines and other healthcare products from drug makers to pharmacies, hospitals, and clinics. It makes money by buying huge volumes of products and delivering them at very small profit margins on each item.
Cencora is a very large business, with about $332.8 billion in revenue over the last 12 months, and revenue grew 5.1%. However, the stock returned -5.8% over the past year while the S&P 500 returned 9.7%, so it has lagged the broader market. The stock is currently 3.7% above its 50-day average and 7.8% above its 200-day average, but it is 9.6% below its 52-week high. Insiders sold $5.0 million of stock over the last 90 days and bought none, and the stock has often moved sharply after earnings reports.
Key numbers
- Market cap: $66.2B
- Revenue (last 12 months): $332.77B
- Revenue growth: +5.1%
- Gross margin: 4.0%
- Operating margin: 0.9%
- P/E: 25.3
- P/S: 0.2
- Debt to equity: 3.75
- Current ratio: 0.93
Quality score
Overall 14/100 · growth 34 · profitability 21 · financial health 0 · value 0
Performance and risk
1-year return -5.8% vs S&P 500 +9.7% · volatility 32.1% (S&P 500 13.8%) · largest drop -32.6% · beta 0.10
Stock move the day after earnings
- 2026-02-04: -8.8%
- 2026-05-06: -17.4%
- 2026-08-05: +3.6%
- 2026-10-21: -0.8%
- 2026-11-04: +4.0%
Insider trades (12 months)
Bought $2.3M · sold $13.5M
COR stock research · COR options calculator · Stocks to buy, hold or sell today
StrikeWright provides AI signals only, not financial advice.